Canada Pension Plan Investment Board Has $20.31 Million Stock Holdings in The Cooper Companies, Inc. (NYSE:COO)

Canada Pension Plan Investment Board increased its position in shares of The Cooper Companies, Inc. (NYSE:COO) by 0.9% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 52,964 shares of the medical device company’s stock after acquiring an additional 460 shares during the period. Canada Pension Plan Investment Board owned about 0.11% of Cooper Companies worth $20,308,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also made changes to their positions in the company. Venturi Wealth Management LLC boosted its position in shares of Cooper Companies by 59.3% during the 2nd quarter. Venturi Wealth Management LLC now owns 86 shares of the medical device company’s stock worth $33,000 after acquiring an additional 32 shares in the last quarter. KB Financial Partners LLC acquired a new stake in Cooper Companies in the first quarter valued at approximately $34,000. Clear Street Markets LLC boosted its position in Cooper Companies by 93.9% in the first quarter. Clear Street Markets LLC now owns 95 shares of the medical device company’s stock valued at $35,000 after buying an additional 46 shares in the last quarter. Colonial Trust Co SC acquired a new stake in Cooper Companies in the first quarter valued at approximately $41,000. Finally, Trivant Custom Portfolio Group LLC acquired a new stake in Cooper Companies in the first quarter valued at approximately $58,000. Institutional investors and hedge funds own 96.31% of the company’s stock.

Analyst Ratings Changes

A number of analysts have weighed in on the stock. Bank of America assumed coverage on shares of Cooper Companies in a research report on Monday, October 30th. They issued a “buy” rating and a $380.00 target price on the stock. Mizuho restated a “buy” rating and issued a $440.00 target price on shares of Cooper Companies in a research report on Monday, August 28th. Stifel Nicolaus restated a “buy” rating and issued a $420.00 target price on shares of Cooper Companies in a research report on Thursday, August 31st. StockNews.com assumed coverage on shares of Cooper Companies in a research report on Thursday, October 5th. They issued a “hold” rating on the stock. Finally, Robert W. Baird raised their target price on shares of Cooper Companies from $400.00 to $410.00 and gave the company an “outperform” rating in a research report on Thursday, August 31st. Three analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $401.30.

Cooper Companies Price Performance

Shares of NYSE:COO opened at $341.51 on Thursday. The firm has a market cap of $16.91 billion, a PE ratio of 61.76, a price-to-earnings-growth ratio of 2.61 and a beta of 0.94. The firm’s fifty day moving average is $326.51 and its 200-day moving average is $359.56. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.99 and a current ratio of 1.72. The Cooper Companies, Inc. has a 52 week low of $301.45 and a 52 week high of $399.62.

Cooper Companies (NYSE:COO) last announced its earnings results on Wednesday, August 30th. The medical device company reported $3.35 earnings per share for the quarter, topping analysts’ consensus estimates of $3.34 by $0.01. Cooper Companies had a net margin of 7.83% and a return on equity of 8.17%. The business had revenue of $930.20 million during the quarter, compared to the consensus estimate of $899.77 million. During the same quarter last year, the firm earned $3.19 earnings per share. Cooper Companies’s quarterly revenue was up 10.3% on a year-over-year basis. Sell-side analysts predict that The Cooper Companies, Inc. will post 12.81 earnings per share for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.